Position in CADL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$356,063
-$922,848 QoQ
Shares Held
72,666
-67.9% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Derivatives in CADL
reported options exposure · as of Mar 31, 2026CallValue
$265,090
CallShares
54,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. CADL ranks #278 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,182,571 | $356,894,009 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,032,298 | $306,561,536 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
4,512,634 | $254,918,694 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,259,444 | $238,097,887 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
453,843 | $237,573,195 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,173,940 | $235,696,783 | |
| 7 | TERN |
Terns Pharmaceuticals, Inc.
|
3,218,810 | $169,695,662 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
1,551,900 | $163,570,260 |
All Filings in CADL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $356,063 | 72,666 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $265,090 | 54,100 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $621,500 | 110,000 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $120,910 | 21,400 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $1,278,911 | 226,356 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $631,890 | 123,900 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $1,286,684 | 252,291 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $169,830 | 33,300 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $190,256 | 37,600 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $1,548,360 | 306,000 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $270,635 | 47,900 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $54,443 | 9,636 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $1,528,325 | 270,500 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $2,448,628 | 282,100 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $2,527,173 | 291,149 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $993,860 | 114,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $589,050 | 85,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $699 | 101 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $177,408 | 25,600 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $373,240 | 60,200 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $88,660 | 14,300 | Put | Defined | 2024-08-14 | |
| 2023-12-31 | $24,772 | 16,852 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $29,579 | 32,152 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $63,684 | 47,174 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $52,912 | 16,851 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||